Profiling for novel proteomics biomarkers in neurodevelopmental disorders

References

• Solassol J, Rouanet P, Lamy PJ et al. Serum protein signature may improve detection of ductal carcinoma in situ of the breast. Oncogene29(4), 550–560 (2010).
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhao S, Fan Y et al. Detection and identification of potential biomarkers of non-small cell lung cancer. Technol. Cancer Res. Treat.8(6), 455–466 (2009).
   PubMed Web of Science ®Google Scholar
• Al-Ruwaili JA, Larkin SE, Zeidan BA et al. Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis. Cancer Genomics Proteomics7(2), 93–103 (2010).
   PubMedGoogle Scholar
• Guo J, Sun Z, Xiao S et al. Proteomic analysis of the cerebrospinal fluid of Parkinson’s disease patients. Cell Res.19(12), 1401–1403 (2009).
   PubMed Web of Science ®Google Scholar
• Novikova SI, He F, Cutrufello NJ, Lidow MS. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis. Neurobiol. Dis.23(1), 61–76 (2006).
   PubMed Web of Science ®Google Scholar
• Villemagne VL, Perez KA, Pike KE et al. Blood-borne amyloid-β dimer correlates with clinical markers of Alzheimer’s disease. J. Neurosci.30(18), 6315–6322 (2010).
   PubMedGoogle Scholar
• Snow A, Gozal D, Valdes R Jr, Jortani SA. Urinary proteins for the diagnosis of obstructive sleep apnea syndrome. Methods Mol. Biol.641, 325–346 (2010).
   PubMedGoogle Scholar
• Paweletz CP, Wiener MC, Bondarenko AY et al. Application of an end-to-end biomarker discovery platform to identify target engagement markers in cerebrospinal fluid by high resolution differential mass spectrometry. J. Proteome Res.9(3), 1392–1401 (2010).
   PubMed Web of Science ®Google Scholar
• Wang H, Malone JP, Gilmore PE et al. Serum markers may distinguish biliary atresia from other forms of neonatal cholestasis. J. Pediatr. Gastroenterol. Nutr.50(4), 411–416 (2010).
   PubMedGoogle Scholar
• Magagnotti C, Fermo I, Carletti RM, Ferrari M, Bachi A. Comparison of different depletion strategies for improving resolution of the human urine proteome. Clin. Chem. Lab. Med.48(4), 531–535 (2010).
   PubMedGoogle Scholar
• Siegmund R, Kiehntopf M, Deufel T. Evaluation of two different albumin depletion strategies for improved analysis of human CSF by SELDI-TOF-MS. Clin. Biochem.42 (10–11), 1136–1143 (2009).
   PubMed Web of Science ®Google Scholar
• Mahn A, Reyes A, Zamorano M, Cifuentes W, Ismail M. Depletion of highly abundant proteins in blood plasma by hydrophobic interaction chromatography for proteomic analysis. J. Chrom. B.878(15–16), 1038–1044 (2010).
   PubMed Web of Science ®Google Scholar
• Taurines R, Dudley E, Conner AC et al. Serum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry. Eur. Arch. Psychiatry Clin. Neurosci.260(3), 249–255 (2010).
   PubMed Web of Science ®Google Scholar
• Kay R, Barton C, Ratcliffe L et al. Enrichment of low molecular weight serum proteins using acetonitrile precipitation for mass spectrometry based proteomic analysis. Rap. Comm. Mass Spec.22(20), 3255–3260 (2008).
   PubMed Web of Science ®Google Scholar
• Nanni P, Levander F, Roda G, Caponi A, James P, Roda A. A label-free nano-liquid chromatography-mass spectrometry approach for quantitative serum peptidomics in Crohn’s disease patients. J. Chrom. B.877(27), 3127–3136 (2009).
   PubMedGoogle Scholar
• Harmsen MM, Jansen J, Westra DF, Coco-Martin JM. Characterization of foot-and-mouth disease virus antigen by surface-enhanced laser desorption ionization-time of flight-mass spectrometry in aqueous and oil-emulsion formulations. Vaccine28(19), 3363–3370 (2010).
   PubMedGoogle Scholar
• Zhang Q, Wang J, Dong R, Yang S, Zheng S. Identification of novel serum biomarkers in child nephroblastoma using proteomics technology. Mol. Biol. Rep.38(1), 631–638 (2010).
   PubMedGoogle Scholar
• Lu HB, Zhou JH, Ma YY et al. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer. Jpn. J. Clin. Oncol.40(4), 336–342 (2010).
   PubMedGoogle Scholar
• Pradeep AR, S TM, Garima G, Raju A. Serum levels of oncostatin M (a gp 130 cytokine): an inflammatory biomarker in periodontal disease. Biomarkers15(3), 277–282 (2010).
   PubMed Web of Science ®Google Scholar
• Zhen H, Yang S, Wu H et al. LyGDI is a promising biomarker for ovarian cancer. Int. J. Gynecol. Cancer.20(3), 316–322 (2010).
   PubMedGoogle Scholar
• Hellstrom I, Heagerty PJ, Swisher EM et al. Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms. Cancer Lett.296(1), 43–48 (2010).
   PubMed Web of Science ®Google Scholar
• Wu CC, Peng PH, Chang YT et al. Identification of potential serum markers for nasopharyngeal carcinoma from a xenografted mouse model using Cy-dye labeling combined with three-dimensional fractionation. Proteomics8(17), 3605–3620 (2008).
   PubMed Web of Science ®Google Scholar
• Diz AP, Dudley E, Macdonald BW et al. Genetic variation underlying protein expression in eggs of the marine mussel Mytilus edulis. Mol. Cell Proteomics8, 132–144 (2009).
   PubMedGoogle Scholar
• O’Hayre M, Salanga CL, Dorrestein PC, Handel TM. Phosphoproteomic analysis of chemokine signaling networks. Methods Enzymol.460, 331–346 (2009).
   PubMedGoogle Scholar
• Ding S, Bond AE, Lemiere F et al. Online immobilized metal affinity chromatography/ mass spectrometry analysis of changes elicited by cCMP in the murine brain phosphoproteome. Rap. Comm. Mass Spec.22(24), 4129–4138 (2008).
   PubMedGoogle Scholar
• Bond AE, Dudley E, Tuytten R et al. Identification of Rab23 phosphorylation as a response to challenge by cytidine 3´5´-cyclic monophosphate, a putative second messenger, in mouse brain. Rapid Comm. Mass Spec.21(16), 2685–2692 (2007).
   PubMedGoogle Scholar
• Cirulli C, Chiappetta G, Marino G, Mauri P, Amoresano A. Identification of free phosphopeptides in different biological fluids by a mass spectrometry approach. Anal. Bioanal. Chem.392 (1–2), 147–159 (2008).
   PubMedGoogle Scholar
• Abbott KL, Lim JM, Wells L, Benigno BB, McDonald JF, Pierce M. Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis. Proteomics10(3), 470–481 (2010).
   PubMed Web of Science ®Google Scholar
• Liu Y, He J, Li C et al. Identification and confirmation of biomarkers using an integrated platform for quantitative analysis of glycoproteins and their glycosylations. J. Proteome Res.9(2), 798–805 (2010).
   PubMedGoogle Scholar
• Haqqani AS, Hutchison JS, Ward R, Stanimirovic DB. Biomarkers and diagnosis; protein biomarkers in serum of pediatric patients with severe traumatic brain injury identified by ICAT-LC-MS/MS. J. Neurotrauma24(1), 54–74 (2007).
   PubMedGoogle Scholar
• Kang UB, Ahn Y, Lee JW. Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker. BMC Cancer10, 114 (2010).
   PubMedGoogle Scholar
• Kolla V, Jenö P, Moes S et al. Quantitative proteomics analysis of maternal plasma in Down syndrome pregnancies using isobaric tagging reagent (iTRAQ). J. Biomed. Biotechnol.2010, 952047 (2010).
   PubMedGoogle Scholar
• Zhou L, Beuerman RW, Chan CM et al. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. J. Proteome Res.8(11), 4889–4905 (2009).
   PubMed Web of Science ®Google Scholar
• Nelson PG, Kuddo T, Song EY et al. Selected neurotrophins, neuropeptides, and cytokines: developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome. Int. J. Neurosci.24(1), 73–80 (2006).
   Google Scholar
• Vellaichamy A, Tran JC, Catherman AD et al. Size-sorting combined with improved nanocapillary liquid chromatography-mass spectrometry for identification of intact proteins up to 80 kDa. Anal. Chem.82(4), 1234–1244 (2010).
   PubMed Web of Science ®Google Scholar
• Lee JE, Kellie JF, Tran JC et al. A robust two-dimensional separation for top-down tandem mass spectrometry of the low-mass proteome. J. Am. Soc. Mass Spectrom.20(12), 2183–2191 (2009).
   PubMed Web of Science ®Google Scholar
• Riikonen R, Makkonen I, Vanhala R, Turpeinen U, Kuikka J, Kokki H. Cerebrospinal fluid insulin-like growth factors IGF-1 and IGF-2 in infantile autism. Dev. Med. Child Neurol.48(9), 751–757 (2006).
   PubMed Web of Science ®Google Scholar
• Emanuele E, Orsi P, Barale F, di Nemi SU, Bertona M, Politi P. Serum levels of vascular endothelial growth factor and its receptors in patients with severe autism. Clin. Biochem.43(3), 317–319 (2010).
   PubMed Web of Science ®Google Scholar
• Boso M, Emanuele E, Politi P et al. Reduced plasma apelin levels in patients with autistic spectrum disorder. Arch Med Res.38(1), 70–74 (2007).
   PubMed Web of Science ®Google Scholar
• Fujita-Shimizu A, Suzuki K, Nakamura K et al. Decreased serum levels of adiponectin in subjects with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry34(3), 455–458 (2010).
   PubMedGoogle Scholar
• Kajizuka M, Miyachi T, Matsuzaki H et al. Serum levels of platelet-derived growth factor BB homodimers are increased in male children with autism. Prog. Neuropsychopharmacol. Biol. Psychiatry34(1), 154–158 (2010).
   PubMedGoogle Scholar
• Iwata Y, Tsuchiya KJ, Mikawa S et al. Serum levels of P-selectin in men with high-functioning autism. Br. J. Psychiatry193(4), 338–339 (2008).
   PubMedGoogle Scholar
• Tsuchiya KJ, Hashimoto K, Iwata Y et al. Decreased serum levels of platelet-endothelial adhesion molecule (PECAM-1) in subjects with high-functioning autism: a negative correlation with head circumference at birth. Biol. Psychiatry62(9), 1056–1058 (2007).
   PubMedGoogle Scholar
• Dettmer K, Hanna D, Whetstone P, Hansen R, Hammock BD. Autism and urinary exogenous neuropeptides: development of an on-line SPE-HPLC-tandem mass spectrometry method to test the opioid excess theory. Anal. Bioanal. Chem.388(8), 1643–1651 (2007).
   PubMed Web of Science ®Google Scholar
• Cass H, Gringras P, March J et al. Absence of urinary opioid peptides in children with autism. Arch. Dis. Child.93(9), 745–750 (2008).
   PubMed Web of Science ®Google Scholar
• Tordjman S, Anderson GM, Botbol M et al. Pain reactivity and plasma β-endorphin in children and adolescents with autistic disorder. PLoS One4(8), e5289 (2009).
   PubMedGoogle Scholar
• Onore C, Enstrom A, Krakowiak P et al. Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders. J. Neuroimmunol.216(1–2), 126–129 (2009).
   PubMedGoogle Scholar
• Heuer L, Ashwood P, Schauer J et al. Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res.1(5), 275–283 (2008).
   PubMed Web of Science ®Google Scholar
• Enstrom A, Krakowiak P, Onore C et al. Increased IgG4 levels in children with autism disorder. Brain Behav. Immun.23(3), 389–395 (2009).
   PubMed Web of Science ®Google Scholar
• Croen LA, Goines P, Braunschweig D et al. Brain-derived neurotrophic factor and autism: maternal and infant peripheral blood levels in the Early Markers for Autism (EMA) Study. Autism Res.1(2), 130–137 (2008).
   PubMed Web of Science ®Google Scholar
• Bailey AR, Giunta BN, Obregon D et al. Peripheral biomarkers in autism: secreted amyloid precursor protein-α as a probable key player in early diagnosis. Int. J. Clin. Exp. Med.1(4), 338–344 (2008).
   PubMed Web of Science ®Google Scholar
• Blardi P, de Lalla A, D’Ambrogio T et al. Long-term plasma levels of leptin and adiponectin in Rett syndrome. Clin. Endocrinol. (Oxf).70(5), 706–709 (2008).
   PubMedGoogle Scholar
• Emanuele E, Boso M, Brondino N et al. Increased serum levels of high mobility group box 1 protein in patients with autistic disorder. Prog. Neuropsych. Biol. Psychiatry34(4), 681–683 (2010).
   PubMed Web of Science ®Google Scholar
• Kajizuka M, Miyachi T, Matsuzaki H et al. Serum levels of platelet-derived growth factor BB homodimers are increased in male children with autism. Prog. Neuropsych. Biol. Psychiatry34(1), 154–158 (2010).
   PubMedGoogle Scholar
• Warren RP, Odell JD, Warren WL, Burger RA, Maciulis A, Torres AR. Is decreased blood plasma concentration of the complement C4B protein associated with attention-deficit hyperactivity disorder? J. Am. Acad. Child Adolesc. Psychiatry34(8), 1009–1014 (1995).
   PubMedGoogle Scholar
• Kopecková M, Paclt I, Goetz P. Polymorphisms and low plasma activity of dopamine-β-hydroxylase in ADHD children. Neuro. Endocrinol. Lett.27(6), 748–754 (2006).
   PubMed Web of Science ®Google Scholar
• Castagnola M, Messana I, Inzitari R et al. Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders. J. Proteome Res.7(12), 5327–5332 (2008).
   PubMed Web of Science ®Google Scholar
• Corbett BA, Kantor AB, Schulman H et al. A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins. Mol. Psychiatry12(3), 292–306 (2007).
   PubMed Web of Science ®Google Scholar
• MacLean B, Tomazela DM, Shulman N et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics26(7), 966–968 (2010).
   PubMed Web of Science ®Google Scholar